drugset / Trial / NCT00356603

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

NCT00356603

Phase 3 Completed 75 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg kit product for the treatment of migraine or cluster headache attacks in clinical settings, to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness) and rate of successful self-injection.

Timeline

Start
2006-06-20
Primary completion
2006-08-07
Completion
2006-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sumatriptan Unknown 3 mg Other

Indications